Načítá se...
Nusinersen as a Therapeutic Agent for Spinal Muscular Atrophy
The reduction of survival motor neuron (SMN) protein causes spinal muscular atrophy (SMA), an autosomal recessive neuromuscular disease. Nusinersen is an antisense oligonucleotide, approved by the FDA, which specifically binds to the repressor within SMN2 exon 7 to enhance exon 7 inclusion and augme...
Uloženo v:
| Vydáno v: | Yonsei Med J |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Yonsei University College of Medicine
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7105407/ https://ncbi.nlm.nih.gov/pubmed/32233169 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2020.61.4.273 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|